Tag: Drugs (Pharmaceuticals)

Surgery for Blocked Arteries Is Often Unwarranted, Researchers Find

The findings of a large federal study on bypass surgeries and stents call into question the medical care provided to tens of thousands of heart disease patients with blocked coronary arteries, scientists reported at the annual meeting of the American Heart Association on Saturday. The new study found that patients who received drug therapy alone […]

Read More

Whoops. Judge Reduces J&J Opioid Fine After Mistaking Thousands for Millions

In a mortifying mistake destined to be cited by gleeful math teachers everywhere, an Oklahoma judge acknowledged that he was three decimal places off — mistaking thousands for millions — when he originally calculated the amount Johnson & Johnson should pay for its role in the state’s opioids crisis. As a result, Judge Thad Balkman […]

Read More

To Drive Down Insulin Prices, W.H.O. Will Certify Generic Versions

With insulin prices skyrocketing and substantial shortages developing in poorer countries, the World Health Organization said on Wednesday that it would begin testing and approving generic versions of the drug. Agency officials said they hoped to drive down insulin prices by encouraging makers of generic drugs to enter the market, increasing competition. At the moment, […]

Read More

Who Owns H.I.V.-Prevention Drugs? The Taxpayers, U.S. Says

After years of prodding by patient advocates, federal officials on Wednesday sued the drug maker Gilead Sciences, charging that it had infringed government patents on the idea of preventing H.I.V. with a daily pill. The suit, by the Department of Health and Human Services, came as a pleasant shock to many critics of the company, […]

Read More

Trump Administration Sues Gilead, Maker of H.I.V.-Prevention Drugs

The Trump administration on Wednesday sued Gilead Sciences, a pharmaceutical company that sells H.I.V.-prevention drugs that can cost patients up to $20,000 a year, accusing the company of earning billions from research funded by taxpayers without paying taxpayers back. The government said the company infringed upon patents owned by the Department of Health and Human […]

Read More

Innovative Drugs Save Lives Only if People Can Afford Them

A bill now making its way through the House could finally provide relief from the sky-high drug prices that have become a hallmark of the American health care industry. But to get there, Americans will need to accept a trade-off that other advanced nations have long since come around to: Slightly fewer new drugs will […]

Read More

Studies Yield ‘Impressive’ Results in Fight Against Cystic Fibrosis

A pair of new studies report “impressive” benefits from a drug therapy for cystic fibrosis, a deadly and devastating disease that affects tens of thousands of people worldwide, the director of the National Institutes of Health wrote in an editorial published in The New England Journal of Medicine on Thursday. “These findings indicate that it […]

Read More

U.S. Blames Drug Shortages on Low Prices and a ‘Broken Marketplace’

Chronic drug shortages that threaten patient care are caused by rock-bottom prices for older generic medicines and a health care marketplace that doesn’t run on the rules of supply and demand, among other factors, according to a federal report published on Tuesday. The report, the work of a task force led by the Food and […]

Read More

Johnson & Johnson Says Recalled Baby Powder Doesn’t Have Asbestos

Johnson & Johnson said on Tuesday that it did not find asbestos in multiple tests of a bottle of baby powder that the Food and Drug Administration said contained trace amounts of the carcinogen. The company had recalled 33,000 bottles of the product earlier this month after the regulator said it discovered evidence of chrysotile […]

Read More

Generic Version of Xanax Is Recalled by F.D.A.

ImageAlprazolam, a generic version of Xanax, is prescribed to manage anxiety and panic disorders.Credit…Science History Images, via Alamy The Food and Drug Administration has announced a nationwide recall of a batch of alprazolam, a generic version of Xanax, because of potential contamination. The manufacturer, Mylan Pharmaceuticals, said Friday that the voluntary recall was because of […]

Read More

How to Win Impeachment

Listen and subscribe to our podcast from your mobile device: Apple Podcasts | Spotify | Google Play | RadioPublic | Stitcher Right now, impeachment seems destined to end with President Trump’s acquittal in the Republican-controlled Senate. But is there anything Democrats can do to change that outcome? This week on “The Argument,” the columnists discuss […]

Read More

That New Alzheimer’s Drug? Don’t Get Your Hopes Up Yet

Biogen, the drug company, said on Tuesday that it would ask the Food and Drug Administration to approve an experimental drug, aducanumab, to treat people with mild cognitive impairment and the earliest signs of Alzheimer’s disease. About 10 million Americans might qualify for treatment if the drug were approved, according to Michel Vounatsos, the company’s […]

Read More

Major Drug Companies Agree to Last-Minute Settlement of Opioid Trial

CLEVELAND — The three major drug distributors and an opioid manufacturer have reached a settlement to avoid the landmark first federal opioid trial that was set to begin here Monday. The deal was struck in the early dawn hours and is expected to be announced in court this morning. People familiar with the discussions said […]

Read More

Judge Summons Drug C.E.O.s for Talks on Sweeping Opioid Settlement

CLEVELAND — A mayor of a small West Virginia city brought to its knees by opioids and representatives of large cities and counties left reeling by the epidemic will gather in federal court here on Friday morning, to sit side by side with chief executives from the country’s largest drug distributors. Along with platoons of […]

Read More

Drug Giants Pursuing $50 Billion Settlement of Opioid Cases

CLEVELAND — As a critical trial deadline bears down, lawyers for states and the three largest drug distributors in the country, along with two manufacturers, have agreed on a framework for a deal to resolve thousands of opioid cases with a settlement worth nearly $50 billion in cash and addiction treatments. Three people familiar with […]

Read More

The China Connection: How One D.E.A. Agent Cracked a Global Fentanyl Ring

Around 3 a.m. on Saturday, Jan. 3, 2015, Laura and Jason Henke awoke with a start at their home in Minot, N.D. Their dog was barking wildly. At the door, in the early morning shadows, they found a police officer and, behind him, a pastor. The officer asked to see Laura’s ID to confirm that […]

Read More

What Are the Benefits of CBD?

The CBD industry is flourishing, conservatively projected to hit $16 billion in the United States by 2025. Already, the plant extract is being added to cheeseburgers, toothpicks and breath sprays. More than 60 percent of CBD users have taken it for anxiety, according to a survey of 5,000 people, conducted by the Brightfield Group, a […]

Read More

Faced With a Drug Shortfall, Doctors Scramble to Treat Children With Cancer

A critical drug that serves as the backbone of treatment for most childhood cancers, including leukemias, lymphomas and brain tumors, has become increasingly scarce, and doctors are warning that they may soon be forced to consider rationing doses. Persistent shortages of certain drugs and medical supplies have plagued the United States for years, but physicians […]

Read More

Rx for Doctors: Stop With the Urine Tests

It’s such a common routine in a doctor’s office or clinic or hospital that patients tend to comply without thinking: Step on the scale, roll up your sleeve for the blood pressure cuff, urinate into a cup. But that last request should prompt questions, at the least. The urine test is the first step into […]

Read More

One Doctor. 25 Deaths. How Could It Have Happened?

COLUMBUS, Ohio — Dad was dying, the doctor told James Allen’s family members as they clustered by his hospital bed. Mr. Allen’s family was stunned. He had suffered a heart attack and was on a ventilator in the hushed intensive care unit of Mount Carmel West, a Catholic hospital in a working-class corner of Columbus. […]

Read More

Scientists Designed a Drug for Just One Patient. Her Name Is Mila.

A new drug, created to treat just one patient, has pushed the bounds of personalized medicine and has raised unexplored regulatory and ethical questions, scientists reported on Wednesday. The drug, described in the New England Journal of Medicine, is believed to be the first “custom” treatment for a genetic disease. It is called milasen, named […]

Read More